# Fresenius Kabi Oncology Limited – FDA Inspection, Jan 18, 2013

Source: https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-limited/283b6f0d-f1b9-4603-a26a-cfee0923ba0c
Source feed: FDA_Inspections

> FDA inspection 815170 of Fresenius Kabi Oncology Limited, January 18, 2013. Classification: Official Action Indicated (OAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 815170
- Company Name: Fresenius Kabi Oncology Limited
- Inspection Date: 2013-01-18
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1013712 - 2017-05-24](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-limited/d569f1f7-caae-429c-9a4e-d98d64f869b0)
- [FDA Inspection 924144 - 2015-03-03](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-limited/e6ceb42f-c280-4ff5-be6b-a075e5e17c43)
- FDA Inspection 630128 - 2009-11-06

Company: https://www.keypedia.com/companies/fresenius-kabi-oncology-limited/c145255a-d691-4f05-8873-bf1e09b6aa97

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c